Clinical Trials Browser

Recruiting × Rhabdomyosarcoma, Embryonal × Dactinomycin × Clear all

NCT05304585 2026-02-24

Chemotherapy for the Treatment of Patients With Newly Diagnosed Very Low-Risk and Low Risk Fusion Negative Rhabdomyosarcoma

Phase 3 Recruiting

Rhabdomyosarcoma, Embryonal